- Investing Ideas
- /
- Global Pharmaceuticals & Biotech The Future Is Online
Global Pharmaceuticals & Biotech The Future Is Online
UPDATED Dec 10, 2023
A list of some of the world's largest online retailers.
335 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SRPTSarepta Therapeutics | US$87.03 | 1.1% | -28.4% | US$8.1b | US$139.22 | PS7.4x | E66.7% | n/a | ||
| ROIVRoivant Sciences | US$9.83 | -1.1% | 38.6% | US$7.9b | US$15.75 | PS76.6x | E35.9% | n/a | ||
| IMGNImmunoGen | US$29.21 | -0.03% | 476.1% | US$7.8b | US$29.48 | PS27.2x | E59.4% | n/a | ||
| KRTXKaruna Therapeutics | US$205.48 | 4.0% | -2.4% | US$7.8b | US$265.26 | PS1306.8x | E54.3% | n/a | ||
| JAZZJazz Pharmaceuticals | US$120.42 | -0.8% | -21.1% | US$7.6b | US$193.00 | PE94.8x | E25.5% | n/a | ||
| CERECerevel Therapeutics Holdings | US$41.22 | 29.6% | 52.5% | US$7.4b | US$36.60 | PB27.3x | E-6.1% | n/a | ||
| APLSApellis Pharmaceuticals | US$62.73 | -1.8% | 21.3% | US$7.4b | US$73.75 | PS27.2x | E71.8% | n/a | ||
| STVNStevanato Group | US$27.82 | 6.0% | 63.1% | US$7.4b | US$33.84 | PE46.2x | E14.6% | 0.2% | ||
| NTRANatera | US$58.15 | -2.0% | 48.3% | US$7.0b | US$71.87 | PS7.1x | E52.5% | n/a | ||
| IONSIonis Pharmaceuticals | US$48.69 | -5.4% | 27.3% | US$7.0b | US$54.38 | PS11.4x | E25.3% | n/a | ||
| EXELExelixis | US$22.00 | -1.9% | 36.8% | US$6.8b | US$25.75 | PE74.3x | E33.9% | n/a | ||
| CTLTCatalent | US$37.18 | -7.0% | -18.3% | US$6.7b | US$49.29 | PS1.6x | E83.4% | n/a | ||
| ELANElanco Animal Health | US$12.80 | -0.2% | 1.3% | US$6.3b | US$13.33 | PS1.4x | E96.5% | n/a | ||
| ASNDAscendis Pharma | US$107.69 | 2.5% | -12.1% | US$6.1b | US$141.62 | PS37.2x | E61.8% | n/a | ||
| ITCIIntra-Cellular Therapies | US$60.29 | -1.9% | 14.4% | US$5.8b | US$77.54 | PS13.8x | E72.2% | n/a | ||
| TXG10x Genomics | US$48.84 | 5.5% | 39.1% | US$5.8b | US$54.83 | PS9.8x | E57.1% | n/a | ||
| IMVTImmunovant | US$39.19 | -4.0% | 166.6% | US$5.7b | US$49.33 | PB22.5x | E35.2% | n/a | ||
| BBIOBridgeBio Pharma | US$32.52 | 1.8% | 256.2% | US$5.7b | US$47.82 | PS600.1x | E32.1% | n/a | ||
| ABCMAbcam | US$23.99 | 0.08% | 54.7% | US$5.5b | US$23.66 | PE1758.5x | E39.3% | 0% | ||
| ISEEIVERIC bio | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
| DPHDechra Pharmaceuticals | UK£38.32 | 0.1% | 41.0% | UK£4.4b | UK£38.18 | PS5.7x | E65.5% | 0% | ||
| PCVXVaxcyte | US$56.67 | 4.6% | 28.3% | US$5.4b | US$66.00 | PB3.8x | E-9.6% | n/a | ||
| HALOHalozyme Therapeutics | US$39.95 | -0.4% | -31.2% | US$5.3b | US$51.27 | PE20.8x | E23.9% | n/a | ||
| CRSPCRISPR Therapeutics | US$64.54 | -9.7% | 26.4% | US$5.1b | US$89.68 | PS30.2x | E46.5% | n/a |